1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonian syndrome in Macaca fascicularis: Which midbrain dopaminergic neurons are lost?

Neuroscience

Volumn 24, Issue 1, 1988, Pages 161-174

  German, D C ^a   Dubach, M ^b   Askari, S ^a   Speciale, S G ^a   Bowden, D M ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; DOPAMINERGIC NERVE CELL; MACACA; MONKEY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; VENTRAL TEGMENTUM;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMAL; BEHAVIOR, ANIMAL; DOPAMINE; MACACA FASCICULARIS; MESENCEPHALON; NEURONS; PARKINSON DISEASE, SECONDARY; PYRIDINES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023830780     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(88)90320-X     Document Type: Article

References (47)

1. Estimation of nuclear population from microtome sections
2. Midbrain dopamine neurons in man: effects of Parkinson's disease on the regional distribution of cells
3. Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
4. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics
5. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
6. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man
7. Jacket and swivel tethering systems
8. Current concepts: III. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys
9. Selective neurotoxic effects of n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in subhuman primates and man: A new animal model of Parkinson's disease
10. Evidence for the existence of monoamine-containing neurons in the central nervous system
11. Chronic parkinsonism secondary to intravenous injection of meperidine analogues
12. Preferential vulnerability of A8 dopamine neurons in the primate to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
13. Fluorescence histochemistry of monoamine-containing cell bodies in the brain stem of the squirrel monkey (Saimiri sciureus)
14. Monoamine containing cell bodies in the squirrel monkey brain
15. Monoamine distribution in primate brain.V. Monoaminergic nuclei
16. Localization of nigrostriatal, nigrothalamic and nigrotectal neurons in ventricular coordinates in macaques
17. Morphological and functional aspects of central monoamine neurons
18. Monoamine distribution in primate brain
19. Neurochemical and histochemical characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurones in the mouse
20. Zur pathologischen anatomie des senilen und des parkinsonistischen tremor
21. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
22. Hyperalimentation in primates. A nutritional model
23. Brain dopamine in Parkinson's disease and other neurological disturbances
24. A brainstem atlas of catecholaminergic neurons and serotonergic perikarya in a pigmy primate (Cebuella pygmaea)
25. Parkinsonism-inducing neurotoxin, N-methyl-r-phenyl-l,2,5,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity
26. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset
27. Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hyproxylase immunocytochemical study in monkey
28. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the squirrel monkey
29. Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons
30. Protein measurement with folin phenol reagent
31. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine is toxic to mesencephalic DA neurons in culture
32. Central catecholamine neuron systems: Anatomy and physiology of the dopamine systems
33. Effects of n-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, n-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse
34. Cellular localization of tyrosine hydroxylase by immunohistochemistry
35. Specificity of antisera prepared against pure bovine MAO-B
36. Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat
37. A primate model of hemiparkinsonism based on intranigral injection of MPTP or 6-OHDA
38. Changes in regional glucose metabolism in the mesocortical dopaminergic system of a primate model of Parkinson's disease
39. The organization of catecholamine-containing neurons in the brain of the rhesus monkey (Macaca mulatta)
40. Distribution of catecholamine and indoleamine neurons in the brain of the common marmoset (Callithrix jacchus)
41. Organization of the ascending striatal afferents in monkeys
42. Histochemical mapping of catecholaminergic neurons and their ascending fiber pathways in the rhesus monkey brain
43. Stereotaxic mapping of the monoamine pathways in the rat brain
44. Distinct monoamine oxidase A and B populations in primate brain